Common Contracts

EX-10.12 10 d575899dex1012.htm EX-10.12 Confidential EXECUTION COPY

Development and License Agreement • May 5th, 2020 • Delaware

• Contract Type
  Development and License Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  Delaware

[*] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.

DEVELOPMENT AND LICENSE AGREEMENT between PRINCIPIA BIOPHARMA INC. and ABBVIE BIOTECHNOLOGY LIMITED Dated as of June 9, 2017

Development and License Agreement • August 17th, 2018 • Principia Biopharma Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Development and License Agreement
• Filed
  August 17th, 2018
• Company
  Principia Biopharma Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This Development and License Agreement (the “Agreement”) is made and entered into effective as of June 9, 2017 (the “Effective Date”) by and between Principia Biopharma, Inc., a Delaware corporation (“Licensor”), and AbbVie Biotechnology Limited, a corporation organized under the laws of Bermuda having its place of business at Clarendon House, 2 Church Street, Hamilton HM11, Bermuda (“AbbVie”). Licensor and AbbVie are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”